PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27210058-7	2016	MTT assay and TUNEL assay revealed that metformin (4 mg/ml) and 5-FU (2.5 microg/ml) combination treatment effectively inhibited cell growth and induced apoptosis in OSCC cell lines (HSC2, HSC3 and HSC4) compared to either agent alone.	Metformin	40-49	DnaJ heat shock protein family (Hsp40) member B7	Homo sapiens	189-193	
26359040-1	2015	OBJECTIVE: To investigate the effect of metformin on the proliferation and cell apoptosis of oral squamous cell carcinoma (OSCC) (HSC-3, HSC-4) in vitro and in vivo.	Metformin	40-49	DnaJ heat shock protein family (Hsp40) member B7	Homo sapiens	130-135	
26359040-2	2015	METHODS: HSC-3, HSC-4 cells were treated with metformin at different concentration (2-50 mmol/L) for 24, 48 or 72 hours.	Metformin	46-55	DnaJ heat shock protein family (Hsp40) member B7	Homo sapiens	9-14	
26359040-12	2015	RESULTS: Metformin inhibited proliferation and colony formation of HSC-3, HSC-4 in a time- and dose-dependent manner.	Metformin	9-18	DnaJ heat shock protein family (Hsp40) member B7	Homo sapiens	67-72	
26359040-19	2015	CONCLUSIONS: Metformin could inhibit the growth of OSCC cell line (HSC-3, HSC-4) by reducing cell proliferation and increasing cell apoptosis in vitro and in vivo.	Metformin	13-22	DnaJ heat shock protein family (Hsp40) member B7	Homo sapiens	67-72